Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants

References

1. Archetti I, Horsfall FL, Jr. 1950; Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.. Journal of Experimental Medicine 92:441–446
   [Google Scholar]
2. Baez M, Palese P, Kilbourne ED. 1980; Gene composition of high-yielding influenza vaccine strains obtained by recombination.. Journal of Infectious Diseases 141:362–365
   [Google Scholar]
3. Both GW, Shi CH, Kilbourne ED. 1983; Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication.. Proceedings of the National Academy of Sciences, U.S.A. 80:6996–7000
   [Google Scholar]
4. Cox NJ, Kitame F, Kendal AP, Maassab HF, Naeve C. 1988; Identification of sequence changes in the cold-adapted live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).. Virology 167:554–567
   [Google Scholar]
5. de Jong JC, de Ronde-Verloop FM, Veenendaal-Van Herk TM, Weijers TF, Bijlsma K, Osterhaus ADME. 1988; Antigenic heterogeneity within influenza A (H3N2) virus strains.. Bulletin of the World Health Organization 66:47–55
   [Google Scholar]
6. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H. 1983; Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.. Proceedings of the National Academy of Sciences, U.S.A. 80:70–74
   [Google Scholar]
7. Erickson AH, Kilbourne ED. 1980; Comparative amino acid analysis of influenza A viral proteins.. Virology 100:34–42
   [Google Scholar]
8. Holmdahl R, Bailey C, Enander L, Mayer R, Klareskog L, Moran T, Bona C. 1989; Origin of the autoreactive anti-type II collagen response. II. Specificities, antibody isotypes and usage of V gene families of anti-type II collagen B cells.. Journal of Immunology 142:1881–1886
   [Google Scholar]
9. Horsfall FL, Jr, Tamm I. 1953; Fractional dilution procedure for precise titration of hemagglutinating viruses and hemagglutinin-inhibiting antibodies.. Journal of Immunology 70:253–259
   [Google Scholar]
10. Johansson BE, Kilbourne ED. 1991; Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection.. Journal of Virological Methods 35:109–114
    [Google Scholar]
11. Johansson BE, Kilbourne ED. 1992; Influenza vaccine strain selection: equivalence of two antigenically distinct haemagglutinin variants of 1989 H3N2 influenza A virus in protection of mice.. Vaccine 10:603–606
    [Google Scholar]
12. Johansson BE, Bucher D, Pokorny BA, Mikhail A, Kilbourne ED. 1989; Identification of PR8 M1 protein in influenza virus high-yield reassortants by M1-specific monoclonal antibodies.. Virology 171:634–636
    [Google Scholar]
13. Katz JM, Robertson JS. 1992; WHO-NIH meeting on host cell selection of influenza virus variants.. Vaccine 10:723–725
    [Google Scholar]
14. Katz JM, Naeve CW, Webster RG. 1987; Host cell-mediated variation in H3N2 influenza viruses.. Virology 156:386–395
    [Google Scholar]
15. Katz JM, Wang M, Webster RG. 1990; Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.. Journal of Virology 64:1808–1811
    [Google Scholar]
16. Kilbourne ED. 1969; Future influenza vaccines and the use of genetic recombinants.. Bulletin of the World Health Organization 41:643–645
    [Google Scholar]
17. Kilbourne ED. 1978; Genetic dimorphism in influenza viruses: characterization of stably associated hemagglutinin mutants differing in antigenicity and biological properties.. Proceedings of the National Academy of Sciences, U.S.A. 75:6258–6262
    [Google Scholar]
18. Kilbourne ED. 1987 Influenza pp. 114–116 New York: Plenum Press;
    [Google Scholar]
19. Kilbourne ED. 1980; Influenza: viral determinants of the pathogenicity and epidemicity of an invariant disease of variable occurrence.. Philosophical Transactions of the Royal Society of London Series B 288:291–297
    [Google Scholar]
20. Kilbourne ED, Schulman JL, Schild GC, Schloer G, Swanson J, Bucher D. 1971; Correlated studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.. Journal of Infectious Diseases 124:449–462
    [Google Scholar]
21. Kilbourne ED, Johansson BE, Grajower B. 1990; Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase.. Proceedings of the National Academy of Sciences, U.S.A. 87:786–790
    [Google Scholar]
22. Rajakumar A, Swierkosz EM, Schulze IT. 1990; Sequence of an influenza virus hemagglutinin determined directly from a clinical sample.. Proceedings of the National Academy of Sciences, U.S.A. 87:4154–4158
    [Google Scholar]
23. Ritchey MD, Palese P, Schulman JL. 1977; Differences in protein patterns of influenza A viruses.. Virology 76:122–128
    [Google Scholar]
24. Robertson JS, Nicolson C, Bootman JS, Major D, Robertson EW, Wood JM. 1991; Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus.. Journal of General Virology 72:2671–2677
    [Google Scholar]
25. Rota PA, Shaw MW, Kendal AP. 1989; Cross-protection against microvariants of influenza virus type B by vaccinia viruses expressing haemagglutinins from egg- or MDCK cell-derived subpopulations of influenza virus type B/England/222/82.. Journal of General Virology 70:1533–1537
    [Google Scholar]
26. Saiki RK, Gelfand DH, Stoffel S, Scarf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. 1988; Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.. Science 239:487–194
    [Google Scholar]
27. Schild GC, Oxford JS, de Jong JC, Webster RG. 1983; Evidence for host-cell selection of influenza virus antigenic variants.. Nature, London 303:706–709
    [Google Scholar]
28. Schulman JL, Kilbourne ED. 1963; Experimental transmission of influenza virus infection in mice. I. The period of transmissibility.. Journal of Experimental Medicine 118:257–266
    [Google Scholar]
29. Underwood PA. 1984; An antigenic map of the haemagglutinin of the influenza Hong Kong subtype (H3N2), constructed using mouse monoclonal antibodies.. Molecular Immunology 21:663–671
    [Google Scholar]
30. Usuba O, Schulman JL, Deatly AM, Bona CA, Moran TM. 1990; New method for titration of virus infectivity by immunostaining.. Viral Immunology 3:237–241
    [Google Scholar]
31. Wang M, Katz JM, Webster RG. 1989; Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients.. Journal of Virology 171:275–279
    [Google Scholar]
32. Wood JM, Oxford JS, Dunleavy U, Newman RW, Major D, Robertson JS. 1989; Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.. Virology 171:214–221
    [Google Scholar]